Putting Clients First Drives Growth and Fuels Innovation
Model-Informed Compound Development Track: All-Presenter Panel Discussion
Session panelists include: Xiaoqing (Shaw-ching) Chang, Michael Bartels, Cecilia Tan, Hisham El-Masri, and Hequan Li
Real World Impact + Regulatory Decision Making Track: All-Presenter Panel Discussion
Session panelists include: Jonathan Chauvin, Xavier Pepin, Maxime Le Merdy, Luiza Novaes Borges, Laurence Del Frari, Tausif Ahmed, and Frederico Martins.
On Demand: The Fundamentals of Power Partnerships
Presented by Nate Musser at MIDD+ 2023 on Thursday, February 16th.
Real World Impact + Regulatory Decision Making Track: PBBM Applications to Support Regulatory Interactions
Presented by Luiza Novaes Borges, ANVISA at MIDD+ 2023 on Thursday, February 16th.
Model-Informed Compound Development Track: Application of PBK Modeling and QIVIVE for Prioritization of Chemicals for Toxicity Testing
Presented by Xiaoqing Chang, Inotiv at MIDD+ 2023 on Thursday, February 16th.
On Demand: Making Modeling & Simulation an Everyday Habit in Your Organization
Presented by Denise Morris at MIDD+ 2023 on Thursday, February 16th.
Real World Impact + Regulatory Decision Making Track Poster Presentation: Building of Encorafenib Physiologically Based Pharmacokinetic Model and its Qualification to Predict Drug Drug Interaction with Posaconazole
Presented by Laurence Del Frari, Pierre Fabre at MIDD+ 2023 on Thursday, February 16th.
On Demand: Real World Impact + Regulatory Decision Making Track: Application of PBBM Modeling in Generic Product Development: Regulatory Applications and Case Studies
Presented by Tausif Ahmed, Dr. Reddy's Laboratories at MIDD+ 2023 on Thursday, February 16th.
Model-Informed Compound Development Track: PBPK Regulatory Applications
Presented by Cecilia Tan, EPA at MIDD+ 2023 on Thursday, February 16th.
Model-Informed Compound Development Track: A Biologically Based Model to Quantitatively Assess the Role of the Nuclear Receptors Liver X (LXR), and Pregnane X (PXR) on Chemically Induced Hepatic Steatosis
Presented by Hisham El-Masri, EPA at MIDD+ 2023 on Thursday, February 16th.
Real World Impact + Regulatory Decision Making Track: GastroPlus® Simulations to Monolix™ for Trial Design
Presented by Jonathan Chauvin and Maxime Le Merdy at MIDD+ 2023 on Thursday, February 16th.
Model-Informed Compound Development Track: The Journey Towards Confidence—Bottom Up PBK Modeling for Benzophenone 4
Presented by Hequn Li, Unilever at MIDD+ 2023 on Thursday, February 16th.
Real World Impact + Regulatory Decision Making Track: Advantages of PBBM and PKPD Modeling to Define Dissolution Safe Space
Presented by Xavier Pepin at MIDD+ 2023 on Thursday, February 16th.
Real World Impact + Regulatory Decision-Making Track: Generics for Emerging Markets and Beyond
Presented by Frederico Martins at MIDD+ 2023 on Thursday, February 16th.
Model-Informed Compound Development Track: Use of QSAR-based PBPK models for Regulatory Exposure Assessments
Presented by Michael Bartels, ToxMetrics at MIDD+ 2023 on Thursday, February 16th.
Women in Pharmaceutical Science Roundtable: “Strategies for Moving the Needle on Gender Equity”
Session panelists include: Jill Fiedler-Kelly, Monika Twarogowska, An Do Dela, Arlene Padron, Lindsay Luke, Kyunghee Yang, Nivea Voelkner, Josh Fohey, Brian Musser...
MIDD+ 2023 Awards Ceremony
Presented at MIDD+ 2023 on Wednesday, February 15th.
On Demand: Career Path Design | The Future of a QST/QSP Modeling Scientist
Presented by Brett Howell at MIDD+ 2023 on Wednesday, February 15th.
Discovery + Preclinical Track: All-Presenter Panel Discussion
Session panelists include: Jeff Woodhead, Deanna Mudie, Lonza, Ylva Terelius, ADMEYT AB, Zack Kenz, Lisl Shoda, and Robert Fraczkiewicz.